BRIEF

on EUROPLASMA (EPA:ALEUP)

EUROPLASMA: First Half 2026 Results

Stock price chart of EUROPLASMA (EPA:ALEUP) showing fluctuations.

Europlasma, an industrial group, announced revenues of €22.3 million for the first half of 2026, down from €32.9 million in 2025. This decline is primarily due to reduced production rates in the Industries segment. Operational performance was impacted by high fixed costs and incidents, such as a fire at FDB Industries.

The group's cash position remains precarious, contingent on a €45 million bond issue. Several of its subsidiaries, including FP Industries and FDB Industries, are undergoing liquidation or receivership proceedings. Despite its financial difficulties, Europlasma remains committed to pollution control and decarbonization.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all EUROPLASMA news